About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• Blood viral load predicts HIV transmission better than semen viral load in small study among MSM
• Infectiousness and antiretroviral therapy: reports look set to further fuel the debate
• Albendazole treatment of helminth co-infection in Kenyan HIV patients raises CD4 counts
• Justice Edwin Cameron calls for a campaign against 'misguided criminal laws and prosecutions'
• HIV prevalence and incidence in Uganda on the way up
• Half of Russian XDR-TB patients cured with aggressive treatment
• Updated British HIV pregnancy guidelines published
• Incidence increasing of HIV-associated multicentric Castleman's disease, a relatively rare lymphatic cancer
• Rapid progression of liver fibrosis in HIV-positive gay men recently infected with hepatitis C
• Long-term HIV treatment cuts risk of hardening of coronary artery